University of Wisconsin may collect $4.35 apiece for millions of iPads and iPhones.
NYS Entity Status
NYS Filing Date
MARCH 18, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - M & J 435 LLC
AROUND THE WEB
- Apple must pay $506M for infringing university’s patent
By Joe Mullin - Wednesday Jul 26, 2017
- Trump’s Tough Talk on North Korea Puts Japan’s Leader in Delicate Spot
By JONATHAN SOBLE - Friday Aug 11, 2017
North Korea’s accelerating military advances — and President Trump’s volatile response — could complicate Japan’s close alliance with the United States.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
- 10 'Game of Thrones' reality shows we need now
By Proma Khosla - Sunday Jul 23, 2017
With Game of Thrones ending in 2018, the great lords of HBO have masterminded several spinoffs. That's all fine and well, but what if we just put a Westerosi twist on known commodities? Imagine your favorite reality TV shows, but with a Game of Thrones twist.
Honestly, once you start thinking about it it's hard to resist, so we came up with
a few10 and imagined how they'd play out.
Eunuch Eye for the Straight Girl
Have you noticed how sleek and chic Daenerys’ winter wear is? For someone who’s barely lived in Westeros, let alone in winter, she looks fabulous — thanks to Varys. How do you find the right outfit that says ‘Dragon Queen’ without the baggage of Meereen? What says “I banished my oldest advisor and ravaged the other in bed” but keeps a leader looking relatable? Varys’ inspiration includes the ladies of King’s Landing and his early years in Pentos. Tyrion carries fabric. Read more...More about Entertainment, Television, List, Hbo, and Parody
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]